RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating

Qian Li1, Zhenglan Huang1, Yuhang Peng1

  • 1Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, Department of Clinical Hematology, Chongqing Medical University, Chongqing, China.

Frontiers in Oncology
|September 10, 2021
PubMed

Insights

Ran Binding Protein 3 (RanBP3) is elevated in chronic myeloid leukemia (CML). Silencing RanBP3 inhibits CML cell growth and restores imatinib sensitivity, offering a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Abnormal protein localization drives cancer and drug resistance.
  • CRM1 is a known target, but its cofactor RanBP3's role in CML is unknown.
  • RanBP3 is a CRM1 cofactor involved in nuclear export.

Purpose of the Study:

  • To investigate the role of RanBP3 in chronic myeloid leukemia (CML).
  • To determine if RanBP3 is a potential therapeutic target in CML.

Main Methods:

  • Measured RanBP3 levels in CML patient samples.
  • Utilized shRNA lentivirus to down-regulate RanBP3 in K562 and K562/G01 cells.
  • Assessed cell proliferation, apoptosis, and drug sensitivity in vitro and in vivo (NOD/SCID mice).

Main Results:

  • RanBP3 expression is elevated in CML.
  • RanBP3 silencing inhibited proliferation, induced apoptosis, and enhanced imatinib sensitivity in CML cells.
  • RanBP3 knockdown restored imatinib sensitivity in vivo.

Conclusions:

  • RanBP3 plays a significant role in CML pathogenesis.
  • Targeting RanBP3, alone or with TKIs, may improve CML treatment outcomes.
  • RanBP3 silencing impacts the TGF-β-SMAD2/3-p21 and ERK1/2-BAD pathways.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K